Abstract:Abstract Funding Acknowledgements Type of funding sources: None. Background Recently, a new staging of patients with moderate to severe aortic stenosis (AS) based on extra-aortic valve cardiac damage has been described to stratify the prognostic of both, asymptomatic and symptomatic patients. Purpose To test the mid-term prognostic value of this staging system in patients with asymptomatic moderate to severe AS. Methods We analyzed a retrospective cohort of 96 patients with at least moderate AS who were systematically studied with echocardiography and cardiac magnetic resonance imaging. Patients were classified according to the staging classification of extra-aortic valve damage: no cardiac damage associated with the valve stenosis (Stage 0), left ventricular (LV) damage: LV mass index >95 g/m2 in women and >115 g/m2 in men and or E/E ́ratio >14 and/or LV ejection fraction <50% (Stage 1), mitral valve or left atrial (LA) damage: LA volume >34 ml/m2, and/or atrial fibrillation and/or ≥ moderate mitral regurgitation (Stage 2), tricuspid valve or pulmonary vasculature damage: systolic pulmonary arterial pressure ≥60 mm Hg and/or the presence of moderate or greater tricuspid regurgitation (Stage 3), or right ventricular damage: tricuspid annulus systolic velocity S ́< 9.5 cm/s, TAPSE < 17 mm, and/or RV ejection fraction < 50% (Stage 4). Given the small number of patients in Stages 3 and 4, patients were merged together in a single group. The primary endpoint was all-cause mortality during a follow-up of 5 years, regardless of whether the patient underwent aortic valve replacement. Kaplan-Meier curves and log-rank test of the time-to-death data were used. Results At baseline patients had a mean age of 70.9 years old and 71.9% were male. Most of patients had hypertension (70.8%) and dyslipidemia (55.2%). 20.8% had diabetes mellitus and only 10.4% had previous coronary artery disease. The mean transvalvular gradient was 39 ± 14 mmHg and the mean aortic valve area was 1.04 ± 0.24 cm2. According to the staging scheme, 37 patients were classified in Stage 0 (38.5%), 32 in Stage 1 (33.3%), 23 in Stage 2 (24%) and 4 in the group of Stage 3-4 (4.2%). During 5 years of follow-up, 44 patients developed symptoms (33 dyspnea, 18 angina and 5 syncope), up to 40% of patients underwent aortic valve replacement and 20 patients died (20.8%), 7 of them due to cardiovascular causes. At 5 years, there was a significant decrease in cumulative survival rates according to staging and group 2 presented the worst prognosis in our series: 95.7% in Stage 0, 81.1% in Stage 1, 75% in Stages 3-4 and 65% in Stage 2 (p = 0.04). Conclusions The novel staging scheme based in imaging evaluation of the extra-aortic [T1] cardiac damage provides mid-term prognostic information in patients with moderate to severe AS. Patients without extravalvular damage present an excellent 5-year survival, mortality increases significatively when the damage extends beyond the LV. Abstract Figure. Baseline Characteristics Abstract Figure. Survival Analysis

Long-term predictors of mortality and functional recovery after aortic valve replacement for severe aortic stenosis with left ventricular dysfunction

Echocardiographic Predictors of Left Ventricular Functional Recovery Following Valve Replacement Surgery for Severe Aortic Stenosis.

Predictors of Survival after Aortic Valve Replacement in Patients with Low-Flow and High-Gradient Aortic Stenosis.

Early and long-term survival after aortic valve replacement in septuagenarians and octogenarians with severe aortic stenosis

Mid-term prognostic value of the novel staging of cardiac damage in asymptomatic patients with moderate to severe aortic stenosis

Impact of a New Preoperative Stratification Based on Cardiac Structural Compromise in Patients with Severe Aortic Stenosis Undergoing Valve Replacement Surgery

Evolution and Prognostic Significance of Patient-Reported Symptoms After Intervention in Severe Aortic Stenosis

Prognosis after surgical replacement with a bioprosthetic aortic valve in patients with severe symptomatic aortic stenosis: systematic review of observational studies

Valve-sparing aortic root replacement: Long-term variables significantly associated with mortality and morbidity

Long-term outcome of cardiac surgery in patients with mitral stenosis and severe pulmonary hypertension

Long-term survival and ourtomes a large cohort of patients underwent with Transcatheter Aortic Valve Replacement: an 10-year single center TAVR experience

Comparison between transcatheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction

Medium-term Outcome of Toronto Aortic Valve Replacement: Single Center Experience

Functional continuum: independent predictor of one-year mortality and key decision-making element in older adults with severe aortic stenosis amenable to aortic valve replacement

Clinical Outcomes and Predictive Factor Analysis of Mild-to-moderate or Moderate Functional Mitral Regurgitation after Aortic Valve Replacement in Patients with Severe Aortic Stenosis

Early reduction of left atrial function predicts adverse clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement

Short-Term Outcomes after Transcatheter Aortic Valve Replacement in Predominant Aortic Regurgitation with Left Ventricular Dysfunction.

Echocardiographic predictors of outcome in severe aortic stenosis patients with preserved or reduced ejection fraction

Long-term outcomes and predictors of recurrent aortic regurgitation after aortic valve-sparing and reconstructive cusp surgery: a single centre experience

Long-term outcomes following aortic valve replacement in bioprosthetic vs mechanical valves

Reduced Left Ventricular Global Longitudinal Strain Predicts Prolonged Hospitalization: A Cohort Analysis of Patients Having Aortic Valve Replacement Surgery